Shilpa Medicare signs long-term CDMO pact with NXI Therapeutics to expand global biotech push
Shilpa will deliver end-to-end services including CMC development, process scale-up, GMP clinical supply, and commercial manufacturing support
Shilpa will deliver end-to-end services including CMC development, process scale-up, GMP clinical supply, and commercial manufacturing support
Bengaluru startup targets 100+ enterprise clients and global expansion as it aims to transform pharmaceutical sales, marketing, tenders, and distribution using AI agents
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
The company has also launched Elyara, a portfolio of products in regenerative medical aesthetics focused on non-invasive skin and hair restoration
The private funding rose 38% amid growing international collaborations and CDMO demand
Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets
Health innovations are viewed more positively than food and agricultural technologies
Certification reinforces energy efficiency, sustainability goals, and green manufacturing across SMT’s Surat and Hyderabad facilities
Subscribe To Our Newsletter & Stay Updated